294 related articles for article (PubMed ID: 24219422)
21. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
[TBL] [Abstract][Full Text] [Related]
22. Modulation of the epithelial inflammatory response to rhinovirus in an atopic environment.
Xatzipsalti M; Psarros F; Konstantinou G; Gaga M; Gourgiotis D; Saxoni-Papageorgiou P; Papadopoulos NG
Clin Exp Allergy; 2008 Mar; 38(3):466-72. PubMed ID: 18269670
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE
Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942
[TBL] [Abstract][Full Text] [Related]
24. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Thorax; 2002 Mar; 57(3):237-41. PubMed ID: 11867828
[TBL] [Abstract][Full Text] [Related]
25. Orosomucoid-like 3 Supports Rhinovirus Replication in Human Epithelial Cells.
Liu Y; Bochkov YA; Eickhoff JC; Hu T; Zumwalde NA; Tan JW; Lopez C; Fichtinger PS; Reddy TR; Overmyer KA; Gumperz JE; Coon J; Mathur SK; Gern JE; Smith JA
Am J Respir Cell Mol Biol; 2020 Jun; 62(6):783-792. PubMed ID: 32078788
[TBL] [Abstract][Full Text] [Related]
26. Transcriptome-Level Interactions between Budesonide and Formoterol Provide Insight into the Mechanism of Action of Inhaled Corticosteroid/Long-Acting
Mostafa MM; Rider CF; Wathugala ND; Leigh R; Giembycz MA; Newton R
Mol Pharmacol; 2021 Mar; 99(3):197-216. PubMed ID: 33376135
[TBL] [Abstract][Full Text] [Related]
27. Th17 immunity in children with allergic asthma and rhinitis: a pharmacological approach.
Albano GD; Di Sano C; Bonanno A; Riccobono L; Gagliardo R; Chanez P; Gjomarkaj M; Montalbano AM; Anzalone G; La Grutta S; Ricciardolo FL; Profita M
PLoS One; 2013; 8(4):e58892. PubMed ID: 23573194
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle.
Van Ly D; De Pedro M; James P; Morgan L; Black JL; Burgess JK; Oliver BG
Respir Res; 2013 Nov; 14(1):127. PubMed ID: 24237854
[TBL] [Abstract][Full Text] [Related]
29. Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection.
Korpi-Steiner NL; Valkenaar SM; Bates ME; Evans MD; Gern JE; Bertics PJ
Clin Exp Allergy; 2010 Aug; 40(8):1203-13. PubMed ID: 20545701
[TBL] [Abstract][Full Text] [Related]
30. Human Rhinovirus Infection of Epithelial Cells Modulates Airway Smooth Muscle Migration.
Shariff S; Shelfoon C; Holden NS; Traves SL; Wiehler S; Kooi C; Proud D; Leigh R
Am J Respir Cell Mol Biol; 2017 Jun; 56(6):796-803. PubMed ID: 28257236
[TBL] [Abstract][Full Text] [Related]
31. Inhaled budesonide/formoterol combination.
McGavin JK; Goa KL; Jarvis B
Drugs; 2001; 61(1):71-8; discussion 79-80. PubMed ID: 11217872
[TBL] [Abstract][Full Text] [Related]
32. Disease-specific expression and regulation of CCAAT/enhancer-binding proteins in asthma and chronic obstructive pulmonary disease.
Borger P; Matsumoto H; Boustany S; Gencay MM; Burgess JK; King GG; Black JL; Tamm M; Roth M
J Allergy Clin Immunol; 2007 Jan; 119(1):98-105. PubMed ID: 17208590
[TBL] [Abstract][Full Text] [Related]
33. Th2-type cytokine-induced mucus metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection.
Jakiela B; Gielicz A; Plutecka H; Hubalewska-Mazgaj M; Mastalerz L; Bochenek G; Soja J; Januszek R; Aab A; Musial J; Akdis M; Akdis CA; Sanak M
Am J Respir Cell Mol Biol; 2014 Aug; 51(2):229-41. PubMed ID: 24588727
[TBL] [Abstract][Full Text] [Related]
34. IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium.
Schworer SA; Chason KD; Chen G; Chen J; Zhou H; Burbank AJ; Kesic MJ; Hernandez ML
J Allergy Clin Immunol; 2023 Jun; 151(6):1577-1584.e4. PubMed ID: 36708816
[TBL] [Abstract][Full Text] [Related]
35. Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbation.
Laanesoo A; Urgard E; Periyasamy K; Laan M; Bochkov YA; Aab A; Magilnick N; Pooga M; Gern JE; Johnston SL; Coquet JM; Boldin MP; Wengel J; Altraja A; Bochenek G; Jakiela B; Rebane A
Clin Transl Med; 2021 Jun; 11(6):e427. PubMed ID: 34185416
[TBL] [Abstract][Full Text] [Related]
36. Cluster analysis of nasal cytokines during rhinovirus infection identifies different immunophenotypes in both children and adults with allergic asthma.
Muehling LM; Heymann PW; Carper H; Murphy DD; Rajadhyaksha E; Kennedy J; Early SV; Soto-Quiros M; Avila L; Workman L; Platts-Mills TAE; Woodfolk JA
Clin Exp Allergy; 2022 Oct; 52(10):1169-1182. PubMed ID: 35575980
[TBL] [Abstract][Full Text] [Related]
37. Lanosterol Synthase Regulates Human Rhinovirus Replication in Human Bronchial Epithelial Cells.
McCrae C; Dzgoev A; Ståhlman M; Horndahl J; Svärd R; Große A; Großkopf T; Skujat MA; Williams N; Schubert S; Echeverri C; Jackson C; Guedán A; Solari R; Vaarala O; Kraan M; Rådinger M
Am J Respir Cell Mol Biol; 2018 Dec; 59(6):713-722. PubMed ID: 30084659
[TBL] [Abstract][Full Text] [Related]
38. Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction.
Johnson JR; Pacitto SR; Wong J; Archer EW; Eirefelt S; Miller-Larsson A; Jordana M
Am J Physiol Lung Cell Mol Physiol; 2008 Nov; 295(5):L780-8. PubMed ID: 18776055
[TBL] [Abstract][Full Text] [Related]
39. A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide.
Heuck C; Heickendorff L; Wolthers OD
Arch Dis Child; 2000 Oct; 83(4):334-9. PubMed ID: 10999872
[TBL] [Abstract][Full Text] [Related]
40. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
Takeyama K; Kondo M; Tagaya E; Kirishi S; Ishii M; Ochiai K; Isono K; Tamaoki J
Allergy Asthma Proc; 2014; 35(2):141-7. PubMed ID: 24717791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
